Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and the older Revision: v3.4.1 entry.
    Difference
    0.4%
    Check dated 2026-02-11T10:15:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and the site version was updated to Revision: v3.4.1, which are administrative updates and do not affect core study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:40.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary control added and metadata labels revised (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) replacing the previous QC/Revision label. No core study content, eligibility criteria, or results are affected; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:45:22.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows the updated site revision: Revision: v3.3.4, replacing the prior v3.3.3 tag. This is a minor backend update that does not alter study details.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:14.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with a Washington listing and updated the revision to v3.3.3. Removed the older Washington Locations header and the HHS Vulnerability Disclosure section.
    Difference
    0.2%
    Check dated 2025-12-23T12:36:39.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Minor metadata updates: a PubMed-related note was added and the page revision 3.3.2 is listed, while the PubMed description was shortened and the previous revision 3.2.0 is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.